BioTTT001

· Beijing Bio-Targeting Therapeutics Technology Co., Ltd

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for BioTTT001, covering 2025-11-26 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma. [Phase 1, Phase 2]

See pricing